Eleonora Cinelli (E Cinelli)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 22

Top Topics

Photodynamic Therapy

Atopic Dermatitis

Top Venues

Dermatologic therapy

International journal of dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Expert review of clinical immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Lucia Genco, Teresa Battista, Matteo Noto, Mario De Lucia, Eleonora Cinelli, Massimiliano Scalvenzi, Gabriella Fabbrocini, Matteo Megna
Leg paralysis after photodynamic therapy for lymphomatoid papulosis: A case report. Dermatologic therapy 35 (5) (2022)
Sonia Sofia Ocampo-Garza, Alessia Villani, Eleonora Cinelli, Elisa Camela, Gabriella Fabbrocini, Matteo Megna
Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation. Dermatologic therapy 35 (4) (2022)
Alessia Villani, M Scalvenzi, T Peduto, Eleonora Cinelli, G Fabbrocini, Alessandro Di Stefani
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Matteo Megna, Luca Potestio, Gabriella Fabbrocini, Eleonora Cinelli
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis? Dermatologic therapy 34 (5) (2021)
Matteo Megna, Sonia Sofia Ocampo-Garza, Gabriella Fabbrocini, Eleonora Cinelli, Ruggiero Angelo, Elisa Camela
A case of erythrodermic psoriasis successfully treated with apremilast. Dermatologic therapy (2021)
Ruggiero Angelo, Gabriella Fabbrocini, Eleonora Cinelli, Matteo Megna
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study. Dermatologic therapy (2021)
Ruggiero Angelo, G Fabbrocini, Eleonora Cinelli, S S Ocampo Garza, Elisa Camela, Matteo Megna
Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice. Clinical and experimental dermatology (2021)
Eleonora Cinelli, Gabriella Fabbrocini, Matteo Megna
Real-world experience versus clinical trials: pros and cons in psoriasis therapy evaluation. International journal of dermatology (2021)
Elisa Camela, Sonia Sofia Ocampo-Garza, Eleonora Cinelli, Alessia Villani, Gabriella Fabbrocini, Matteo Megna
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review. Dermatologic therapy 34 (2) (2021)
Matteo Megna, Eleonora Cinelli, Elisa Camela, Gabriella Fabbrocini
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data. Expert review of clinical immunology 16 (6) (2020)
Eleonora Cinelli, Gabriella Fabbrocini, Davide Fattore, Claudio Marasca, Giovanni Damiani, Maria Carmela Annunziata
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 28 (9) (2020)
Alessia Villani, Claudia Costa, Gabriella Fabbrocini, Eleonora Cinelli, Vincenzo Greco, Massimiliano Scalvenzi
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004-2018. International journal of dermatology 59 (12) (2020)
Eleonora Cinelli, Matteo Megna, Adriana Di Guida, Vincenzo Greco, Maria Carmela Annunziata, Gabriella Fabbrocini
Teledermatology for patient management, dermatology education and research during the COVID-19 pandemic. The Australasian journal of dermatology 61 (4) (2020)
Maddalena Napolitano, Marina Vastarella, Gabriella Fabbrocini, Eleonora Cinelli, Elisa Camela, Paolo Tranchini, Luigi Bennardo, Cataldo Patruno
Hereditary angioedema type III, recurrent pregnancy loss and heterozygous MTHFR mutation. Dermatologic therapy 33 (6) (2020)
Matteo Megna, Gabriella Fabbrocini, Maria Ferrillo, Eleonora Cinelli
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: Report of two cases. Dermatologic therapy 33 (6) (2020)
Matteo Megna, G Fabbrocini, E Camela, Eleonora Cinelli
Apremilast efficacy and safety in elderly psoriasis patients over a 48-week period. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (11) (2020)
Eleonora Cinelli, Mariateresa Nocerino, Angela Patrì, Matteo Megna, Gabriella Fabbrocini, Lucia Gallo
Mycoses in the elderly population: what a 16-year experience has taught us. International journal of dermatology 60 (2) (2020)
Matteo Megna, Gabriella Fabbrocini, Ruggiero Angelo, Eleonora Cinelli
Efficacy and safety of risankizumab in psoriasis patients who failed anti-IL-17, anti-12/23 and/or anti IL-23: Preliminary data of a real-life 16-week retrospective study. Dermatologic therapy 33 (6) (2020)
Matteo Megna, Maria Ferrillo, Ruggiero Angelo, Eleonora Cinelli, Lucia Gallo, Gabriella Fabbrocini
QuantiFERON TB-gold conversion rate among psoriasis patients under biologics: a 9-year retrospective study. International journal of dermatology 60 (3) (2020)
Ruggiero Angelo, Gabriella Fabbrocini, Eleonora Cinelli, Matteo Megna
Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti-interleukin-17 treatment: A real-life 52-week retrospective study. Dermatologic therapy 34 (1) (2020)
Sonia Sofia Ocampo-Garza, Gabriella Fabbrocini, Jorge Ocampo Candiani, Eleonora Cinelli, Alessia Villani
Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature. Dermatologic therapy 33 (6) (2020)
Maddalena Napolitano, Massimiliano Scalvenzi, Gabriella Fabbrocini, Eleonora Cinelli, Cataldo Patruno
Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series. Dermatologic therapy 32 (6) (2019)